Children as young as 6 months old have received their initial shot of the Pfizer-BioNTech COVID-19 vaccine as part of a pediatric trial to assess the safety of the vaccine, Pfizer officials announced Thursday, according to NBC News.
The global study of 144 participants will also examine whether the vaccine can generate an immune response in children and determine the proper dosage for each age group in the trial: 6 months to 2 years; 2 years to 5 years; and 5 years to 11 years.
Read more